Involvement of BCL-2 Oncoprotein in the Development of Enterochromaffin-like Cell Gastric Carcinoids

American Journal of Surgical Pathology

Volumn 20, Issue 4, 1996, Pages 433-441

  Azzoni, Cinzia ^a   Doglioni, Claudio ^d   Viale, Giuseppe ^b,c   Delle Fave, Gianfranco ^e   De Boni, Michele ^d   Caruana, Pietro ^a   Ferraro, Gabriella ^a   Bordi, Cesare ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d City Hospital   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atrophic gastritis; BCL 2; ECL cells; Gastric carcinoids; Multiple endocrine neoplasia type 1; Zollinger Ellison syndrome

Indexed keywords

CHROMOGRANIN A; GASTRIN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CARCINOGENESIS; CARCINOID; CELL HYPERPLASIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOCRINE CELL; ENTEROCHROMAFFIN CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGASTRINEMIA; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PROTEIN EXPRESSION; STOMACH TUMOR; ZOLLINGER ELLISON SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; ENTEROCHROMAFFIN CELLS; FEMALE; GASTRIC MUCOSA; GENES, MYC; HUMANS; MALE; MIDDLE AGED; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS;

EID: 0029883963     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199604000-00006     Document Type: Article

References (51)

1. Bhargava V, Kell DL, van de Rijn M, Warnke RA. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 1994;145:534-40.
2. Borch K. Atrophic gastritis and gastric carcinoid tumors. Ann Med 1989;21:291-7.
3. Borch K, Renvall H, Kullman E, Wilander E. Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis: a prospective analysis of 11 cases. Am J Surg Pathol 1987;11:435-44.
4. Bordi C, Costa A, Missale G. ECL cell proliferation and gastrin levels. Gastroenterology 1975;68:205-6.
5. Bordi C, D'Adda T, Azzoni C, Pilato FP. Prolifération des cellules endocrines de la muqueuse fundique de l'homme en dehors des états d'hypergastrinémie. Gastroenterol Clin Biol 1991;15:C51-C58.
6. Bordi C, D'Adda T, Azzoni C, Pilato FP, Baggi MT, Yu J-Y. Hyperplasia of endocrine cells in the human oxyntic mucosa. In: Håkanson R, Sundler F, eds. The stomach as an endocrine organ. Amsterdam: Elsevier, 1991:403-24.
7. Bordi C, D'Adda T, Azzoni C, Pilato FP, Caruana P. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 1959;19(suppl 1):S8-S19.
8. Bordi C, D'Adda T, Pilato FP, Ferrari C. Carcinoid (ECL cell) tumor of the oxyntic mucosa of the stomach: a hormone-dependent neoplasm? In: Fenoglio-Preiser C, Wolf M, Rilke F, eds. Progress in surgical pathology. Philadelphia: Field & Wood, 1988:177-95.
9. Bordi C, Yu J-Y, Baggi MT, et al. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 1991;67:663-72.
10. Bosari S, Moneghini L, Graziani D, Lee AKC, Murray JJ, Coggi G, Viale G. bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas and adenocarcinomas. Hum Pathol 1995;26:534-40.
11. Bronner MP, Culin C, Reed JC, Furth EE. The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 1995;146:20-6.
12. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 1993;143: 1543-50.
13. Cattan D, Roucayrol AM, Launay JM, Callebert J, Courillon-Mallet A. Serum gastrin and argyrophil cell hyperplasia relationships in fundic atrophic gastritis. In: Håkanson R, Sundler F, eds. The stomach as an endocrine organ. Amsterdam: Elsevier, 1991:425-48.
14. Charlotte F, L'Herminé A, Martin N, et al. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994;144:460-5.
15. Colombel M, Symmans F, Gil S, et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 1993;143: 390-400.
16. Correa P, Yardley JH. Grading and classification of chronic gastritis: one american response to the Sydney system. Gastroenterology 1992;102:355-9.
17. Creutzfeldt W. The achlorhydria-carcinoid sequence: role of gastrin. Digestion 1988;39:61-79.
18. D'Adda T, Bertelé A, Pilato FP, Bordi C. Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach. Cell Tissue Res 1989;255:41-8.
19. D'Adda T, Corleto V, Pilato FP, et al. Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology 1990;99:17-26.
20. Doglioni C, Dei Tos AP, Laurino L, Chiarelli C, Barbareschi M, Viale G. The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen status. Virchows Arch 1994;424:47-51.
21. Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol 1985;20(suppl. 108):53-69.
22. Feurle GE. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome. Gut 1994;35:275-7.
23. Gompel A, Sabourin JC, Martin A, et al. Bcl-2 expression in normal endometrium during the menstrual circle. Am J Pathol 1994;144:1195-202.
24. Hague A, Moorghen M, Hicks D, Chapman M, Paraskeva C. BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene 1994;9:3367-70.
25. Håkanson R, Sundler F. Regulation of gastric endocrine cell proliferation. In: Walsh JH, ed. Gastrin. New York: Raven Press, 1993:307-18.
26. Håkanson R, Tielemans Y, Chen D, Andersson K, Mattsson H, Sundler F. Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 1993;105:15-21.
27. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
28. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-5.
29. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993;361:365-9.
30. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. V. Behaviour of enteroendocrine and caveolated cells. General conclusions on cell kinetics in the oxyntic epithelium. Anat Rec 1993;236:333-40.
31. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
32. Lauwers GY, Scott GV, Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 1994;73:2900-4.
33. Matsuyama M, Suzuki H. Differentiation of immature mucus cells into parietal, argyrophil and chief cells in stomach grafts. Science 1970;169:385-7.
34. McDonnel TJ, Troncoso P, Brisbay SM, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992;52:6940-4.
35. Modlin IM, Kim H, Bilchik AJ, Nilsson O, Esterline W, Goldenring JR. Pathobiology of enterochromaffin-like cell tumor induction in mastomys. In: Håkanson R, Sundler F, eds. The stomach as an endocrine organ. Amsterdam: Elsevier, 1991:499-514.
36. Pezzella F, Morrison H, Jones M, et al. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin lymphomas. Histopathology 1993;22:39-44.
37. Pezzella F, Ralfkiaer E, Gatter KC, Mason DY. The 14;18 translocation in European cases of follicular lymphoma: comparison in Southern blotting and the polymerase chain reaction. Br J Haematol 1990;76:58-64.
38. Pezzella F, Turley H, Kuzu I, et al. BCL-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993;329:690-4.
39. Pilotti S, Collini P, Rilke F, Cattoretti G, Delbo R, Pierotti MA. bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 1994; 172:337-42.
40. Poynter D, Selway SAM. Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach. Mutat Res 1991;248:303-19.
41. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104:994-1006.
42. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237-41.
43. Smoller BR, Vanderijn M, Lebrun D, Warnke RA. bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas. Br J Dermatol 1994;131:28-31.
44. Solcia E, Bordi C, Creutzfeldt W, et al. Histopathological classifiction of nonantral gastric endocrine growths in man. Digestion 1988;41:185-200.
45. Solcia E, Capella C, Buffa R, Usellini L, Frigerio B, Fontana P. Endocrine cells of the gastrointestinal tract and related tumors. Pathobiol Ann 1979;9:163-204.
46. Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia: a newly recognized association. Am J Surg Pathol 1990;14: 503-13.
47. Solcia E, Rindi G, Fiocca R, Villani L, Riva C, Capella C. Endocrine proliferations and carcinoids in hypergastrinemia. In: Walsh JH, ed. Gastrin New York: Raven Press, 1993:361-71.
48. Tahara E. Fine structure of several types of endocrine cells in mouse gastric mucosa with special reference to the histogenesis. Hiroshima J Med Sci 1971;20:255-68.
49. Tielemans Y, Håkanson R, Sundler F, Willems G. Proliferation of enterochromaffin like cells in omeprazole-treated hypergastrinemic rats. Gastroenterology 1989;96:723-9.
50. Tielemans Y, Willems G, Sundler F, Håkanson R. Self replication of enterochromaffin-like cells in the mouse stomach. Digestion 1990;45:138-46.
51. Viale G, Roncalli M, Grimelius L, et al. Prognostic value of BCL-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol 1995;26:945-50.